BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 27 Mar · 12:17 IST

Biocon Limited has informed the Exchange regarding 'Amendment in Trust Deed'.

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.1%1-day move
₹379.20
prior close
₹371.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.1-0.2-0.2-5.1-3.9-7.2-6.3-10.3-9.0-5.6-4.6+14.4+9.2
Up moveDown movePending
AI summary

Biocon Limited has filed an amendment (the 7th) to the Biocon India Limited Employees Welfare Trust Deed, originally created in May 2001, solely to effect a change in trustees. Two existing trustees, Mr. Krishnachar Nandakumar and Ms. Maninder Kapoor Puri, will resign with effect from the close of business on March 31, 2026. In their place, Mr. Mukesh Karnath and Mr. Naveen Narayanan will be appointed as new trustees effective April 1, 2026. The trust deed has been amended to reflect the new composition of the Board of Trustees, which now consists of just these two new members. The filing has been made under Regulation 3(3) of SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021, with the settlor of the trust being Biocon's founder Kiran Mazumdar-Shaw.

Likely market impact

This is a routine corporate governance update with no material impact on the company's financials, operations, or shareholder value. The trustee change is administrative in nature and unlikely to move the stock price.